237 related articles for article (PubMed ID: 21184786)
1. Deletion of steroid receptor coactivator-3 gene ameliorates hepatic steatosis.
Ma X; Xu L; Wang S; Cui B; Li X; Xu J; Ning G
J Hepatol; 2011 Aug; 55(2):445-52. PubMed ID: 21184786
[TBL] [Abstract][Full Text] [Related]
2. Deletion of angiotensin II type I receptor reduces hepatic steatosis.
Nabeshima Y; Tazuma S; Kanno K; Hyogo H; Chayama K
J Hepatol; 2009 Jun; 50(6):1226-35. PubMed ID: 19395110
[TBL] [Abstract][Full Text] [Related]
3. A RARE of hepatic Gck promoter interacts with RARα, HNF4α and COUP-TFII that affect retinoic acid- and insulin-induced Gck expression.
Li R; Zhang R; Li Y; Zhu B; Chen W; Zhang Y; Chen G
J Nutr Biochem; 2014 Sep; 25(9):964-76. PubMed ID: 24973045
[TBL] [Abstract][Full Text] [Related]
4. Puerarin ameliorates hepatic steatosis by activating the PPARα and AMPK signaling pathways in hepatocytes.
Kang OH; Kim SB; Mun SH; Seo YS; Hwang HC; Lee YM; Lee HS; Kang DG; Kwon DY
Int J Mol Med; 2015 Mar; 35(3):803-9. PubMed ID: 25605057
[TBL] [Abstract][Full Text] [Related]
5. The role of chicken ovalbumin upstream promoter transcription factor II in the regulation of hepatic fatty acid oxidation and gluconeogenesis in newborn mice.
Planchais J; Boutant M; Fauveau V; Qing LD; Sabra-Makke L; Bossard P; Vasseur-Cognet M; Pégorier JP
Am J Physiol Endocrinol Metab; 2015 May; 308(10):E868-78. PubMed ID: 25783893
[TBL] [Abstract][Full Text] [Related]
6. Activation of peroxisome proliferator-activated receptor alpha by dietary fish oil attenuates steatosis, but does not prevent experimental steatohepatitis because of hepatic lipoperoxide accumulation.
Larter CZ; Yeh MM; Cheng J; Williams J; Brown S; dela Pena A; Bell-Anderson KS; Farrell GC
J Gastroenterol Hepatol; 2008 Feb; 23(2):267-75. PubMed ID: 17868330
[TBL] [Abstract][Full Text] [Related]
7. Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis.
Larter CZ; Yeh MM; Van Rooyen DM; Brooling J; Ghatora K; Farrell GC
J Gastroenterol Hepatol; 2012 Feb; 27(2):341-50. PubMed ID: 21929649
[TBL] [Abstract][Full Text] [Related]
8. All-trans-retinoic acid ameliorates hepatic steatosis in mice by a novel transcriptional cascade.
Kim SC; Kim CK; Axe D; Cook A; Lee M; Li T; Smallwood N; Chiang JY; Hardwick JP; Moore DD; Lee YK
Hepatology; 2014 May; 59(5):1750-60. PubMed ID: 24038081
[TBL] [Abstract][Full Text] [Related]
9. Oxymatrine attenuates hepatic steatosis in non-alcoholic fatty liver disease rats fed with high fructose diet through inhibition of sterol regulatory element binding transcription factor 1 (Srebf1) and activation of peroxisome proliferator activated receptor alpha (Pparα).
Shi LJ; Shi L; Song GY; Zhang HF; Hu ZJ; Wang C; Zhang DH
Eur J Pharmacol; 2013 Aug; 714(1-3):89-95. PubMed ID: 23791610
[TBL] [Abstract][Full Text] [Related]
10. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.
Kang JH; Goto T; Han IS; Kawada T; Kim YM; Yu R
Obesity (Silver Spring); 2010 Apr; 18(4):780-7. PubMed ID: 19798065
[TBL] [Abstract][Full Text] [Related]
11. Transgenic expression of mutant peroxisome proliferator-activated receptor gamma in liver precipitates fasting-induced steatosis but protects against high-fat diet-induced steatosis in mice.
Tanaka T; Masuzaki H; Ebihara K; Ogawa Y; Yasue S; Yukioka H; Chusho H; Miyanaga F; Miyazawa T; Fujimoto M; Kusakabe T; Kobayashi N; Hayashi T; Hosoda K; Nakao K
Metabolism; 2005 Nov; 54(11):1490-8. PubMed ID: 16253638
[TBL] [Abstract][Full Text] [Related]
12. Nuclear receptor binding to the retinoic acid response elements of the phosphoenolpyruvate carboxykinase gene in vivo: effects of vitamin A deficiency.
Scribner KB; Odom DP; McGrane MM
J Nutr Biochem; 2007 Mar; 18(3):206-14. PubMed ID: 16713227
[TBL] [Abstract][Full Text] [Related]
13. Menin prevents liver steatosis through co-activation of peroxisome proliferator-activated receptor alpha.
Cheng P; Yang SS; Hu XG; Zhou XY; Zhang YJ; Jin G; Zhou YQ
FEBS Lett; 2011 Nov; 585(21):3403-8. PubMed ID: 22001208
[TBL] [Abstract][Full Text] [Related]
14. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
15. Aberrant miR199a-5p/caveolin1/PPARα axis in hepatic steatosis.
Li B; Zhang Z; Zhang H; Quan K; Lu Y; Cai D; Ning G
J Mol Endocrinol; 2014 Dec; 53(3):393-403. PubMed ID: 25312970
[TBL] [Abstract][Full Text] [Related]
16. Retinoic acid receptor β stimulates hepatic induction of fibroblast growth factor 21 to promote fatty acid oxidation and control whole-body energy homeostasis in mice.
Li Y; Wong K; Walsh K; Gao B; Zang M
J Biol Chem; 2013 Apr; 288(15):10490-504. PubMed ID: 23430257
[TBL] [Abstract][Full Text] [Related]
17. Astaxanthin reduces hepatic lipid accumulations in high-fat-fed C57BL/6J mice via activation of peroxisome proliferator-activated receptor (PPAR) alpha and inhibition of PPAR gamma and Akt.
Jia Y; Wu C; Kim J; Kim B; Lee SJ
J Nutr Biochem; 2016 Feb; 28():9-18. PubMed ID: 26878778
[TBL] [Abstract][Full Text] [Related]
18. Mindin/Spondin 2 inhibits hepatic steatosis, insulin resistance, and obesity via interaction with peroxisome proliferator-activated receptor α in mice.
Zhu LH; Wang A; Luo P; Wang X; Jiang DS; Deng W; Zhang X; Wang T; Liu Y; Gao L; Zhang S; Zhang X; Zhang J; Li H
J Hepatol; 2014 May; 60(5):1046-54. PubMed ID: 24445216
[TBL] [Abstract][Full Text] [Related]
19. Spironolactone improves glucose and lipid metabolism by ameliorating hepatic steatosis and inflammation and suppressing enhanced gluconeogenesis induced by high-fat and high-fructose diet.
Wada T; Kenmochi H; Miyashita Y; Sasaki M; Ojima M; Sasahara M; Koya D; Tsuneki H; Sasaoka T
Endocrinology; 2010 May; 151(5):2040-9. PubMed ID: 20211973
[TBL] [Abstract][Full Text] [Related]
20. Liver PPARα is crucial for whole-body fatty acid homeostasis and is protective against NAFLD.
Montagner A; Polizzi A; Fouché E; Ducheix S; Lippi Y; Lasserre F; Barquissau V; Régnier M; Lukowicz C; Benhamed F; Iroz A; Bertrand-Michel J; Al Saati T; Cano P; Mselli-Lakhal L; Mithieux G; Rajas F; Lagarrigue S; Pineau T; Loiseau N; Postic C; Langin D; Wahli W; Guillou H
Gut; 2016 Jul; 65(7):1202-14. PubMed ID: 26838599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
